Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure
This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists.
Saved in:
| Main Authors | , |
|---|---|
| Format | Patent |
| Language | English French German |
| Published |
31.05.2006
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists. |
|---|---|
| AbstractList | This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising administering prostaglandin agonists, which ae EP4 receptor selective prostaglandin agonists. |
| Author | PARALKAR, VISHWAS MADHAV THOMPSON, DAVID DUANE |
| Author_xml | – fullname: THOMPSON, DAVID DUANE – fullname: PARALKAR, VISHWAS MADHAV |
| BookMark | eNqNzDsOwjAQRVEXUPDbw5RJgUQ-QtQgA2UKqKORM04imXFkT1g_RmIBVK94R3etFuyZVkqekcBbmIKPgr1D7kaGrLnpModAhibxAWrIdFPnEMmRkfFNgL3nMUoEm24ZCCQQyotYvjU0syTDHZghJGhSitGBxdHNgbZqadFF2v12o-CqH5f7nibfUpzQEJO0uimKqjycjuei-oN8AOn0Q9g |
| ContentType | Patent |
| DBID | EVB |
| DatabaseName | esp@cenet |
| DatabaseTitleList | |
| Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine Chemistry Sciences |
| DocumentTitleAlternate | Utilisation d'activateurs séléctifs du récepteur 4 (ep4) des prostaglandines pour traiter l'insuffisance renale chronique ou aigue Verwendung von Aktivatoren des Prostaglandinrezeptores 4 zur Behandlung von akuter oder chronischer Niereninsuffizienz |
| ExternalDocumentID | EP1132086B1 |
| GroupedDBID | EVB |
| ID | FETCH-epo_espacenet_EP1132086B13 |
| IEDL.DBID | EVB |
| IngestDate | Fri Jul 19 12:57:50 EDT 2024 |
| IsOpenAccess | true |
| IsPeerReviewed | false |
| IsScholarly | false |
| Language | English French German |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-epo_espacenet_EP1132086B13 |
| Notes | Application Number: EP20010300690 |
| OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060531&DB=EPODOC&CC=EP&NR=1132086B1 |
| ParticipantIDs | epo_espacenet_EP1132086B1 |
| PublicationCentury | 2000 |
| PublicationDate | 20060531 |
| PublicationDateYYYYMMDD | 2006-05-31 |
| PublicationDate_xml | – month: 05 year: 2006 text: 20060531 day: 31 |
| PublicationDecade | 2000 |
| PublicationYear | 2006 |
| RelatedCompanies | PFIZER PRODUCTS INC |
| RelatedCompanies_xml | – name: PFIZER PRODUCTS INC |
| Score | 2.649393 |
| Snippet | This invention is directed to methods and compositions of teating acute or chronic renal failure or dysfunction, or conditions caused thereby comprising... |
| SourceID | epo |
| SourceType | Open Access Repository |
| SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| Title | Use of prostaglandin (PGE2) receptor 4 (EP4) selective agonists for the treatment of acute and chronic renal failure |
| URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060531&DB=EPODOC&locale=&CC=EP&NR=1132086B1 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NT4NAEJ001ag3rRrrV-ZgSHsg2gqlHIhJgdqYtCWmNb01sCyGy0IKjX_f2aVFL3rbAJmwk53ZebszbwAeYrMfhtyw9IjxWDdio6fbCWGeoV2xjdtMZbtPZ4PJ0nhbmasGpPtaGMUT-qXIEcmiGNl7qfx1_nOI5ancyuIxSulR9jJeOJ5Wo2O5pjRv5PjB3Ju7muvSSJu9O7KhOkXvIwJKBxRFW9IY_I-RLErJf-8o41M4DEiYKM-gwUULjt1947UWHE1399003JlecQ7lsuCYJZjLMo1Qdd5IBXaCV7_fRXJbPCf0jAZ2_MDoYqHa25Anw_Azk-S4BVJ0ihTtYZ1aLqWFbFvSNyJGVrHkkihaWpjQ3LcbfgE49hfuRKffX9eqWvtBPdHnS2iKTPArwCgxOQ-HT6wXk2McWDazSQMWp1CNAOCQt6H9p5jrf97dwEl1IiEv02-hWW62_I726DK6V9r9Bh_5lgY |
| link.rule.ids | 230,309,783,888,25576,76876 |
| linkProvider | European Patent Office |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT4NAEJ401VhvWjXW5xwMaQ9EW6GUAzEpUKv2QUxremtgWUwvQAqNf9_ZpUUvetuwZLK72Zmdb3fmG4C7UO_4PtcMNWA8VLVQa6tmRJinZxZs4yaT0e7jSXc4114X-qICq10ujOQJ_ZLkiKRRjPQ9l_Y6_bnEcmRsZXYfrOhT8jSYWY5SomOxpxSnb7ne1Jnaim1TS5m8W6KgOnnvfQJKe-RhG0IZ3I--SEpJf58ogyPY90hYnB9Dhcd1qNm7wmt1OBhv37upuVW97ATyecYxiTAVaRq-rLyxirHpPbudFpLZ4imhZ9Sw6XpaCzNZ3oYsGfqfiSDHzZC8UyRvD8vQciHNZ5uc_olDZAVLLomirYURzX2z5qeAA3dmD1Ua_rJcqqXrlRN9PINqnMT8HDCIdM793gNrh2QYu4bJTIIZBidXjQBgjzeg8aeYi3_6bqE2nI1Hy9HL5O0SDovbCfGwfgXVfL3h13Re58GNXOlvVnqY-Q |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Use+of+prostaglandin+%28PGE2%29+receptor+4+%28EP4%29+selective+agonists+for+the+treatment+of+acute+and+chronic+renal+failure&rft.inventor=THOMPSON%2C+DAVID+DUANE&rft.inventor=PARALKAR%2C+VISHWAS+MADHAV&rft.date=2006-05-31&rft.externalDBID=B1&rft.externalDocID=EP1132086B1 |